Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

STK17A Antikörper (N-Term)

STK17A Reaktivität: Human WB, IF, EIA Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN499768
  • Target Alle STK17A Antikörper anzeigen
    STK17A (serine/threonine Kinase 17a (STK17A))
    Bindungsspezifität
    • 15
    • 13
    • 8
    • 6
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reaktivität
    • 62
    • 11
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    Human
    Wirt
    • 55
    • 8
    Kaninchen
    Klonalität
    • 56
    • 7
    Polyklonal
    Konjugat
    • 33
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser STK17A Antikörper ist unkonjugiert
    Applikation
    • 40
    • 20
    • 13
    • 13
    • 7
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA)
    Spezifität
    DRAK1 antibody was raised against a peptide corresponding to amino acids near the amino terminus of human DRAK1. DRAK1 antibody has no cross responses to DRAK2, DAP or ZIP kinases.
    Aufreinigung
    Affinity chromatography purified via peptide column
    Immunogen
    Human DRAK1 (N-Terminus) Peptide
    Isotyp
    IgG
    Top Product
    Discover our top product STK17A Primärantikörper
  • Applikationshinweise
    ELISA. Western Blot: 0.5 - 1 μg/mL. A431 or MOLT4 whole cell lysate can be used as positivecontrol and an approximately 50 kDa band can be detected. Immunocytochemistry.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Buffer
    PBS containing 0.02 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C.
  • Target
    STK17A (serine/threonine Kinase 17a (STK17A))
    Andere Bezeichnung
    STK17A / DRAK1 (STK17A Produkte)
    Synonyme
    STK17A antikoerper, DRAK1 antikoerper, RDRAK1 antikoerper, serine/threonine kinase 17a antikoerper, serine/threonine kinase 17a L homeolog antikoerper, STK17A antikoerper, stk17a antikoerper, stk17a.L antikoerper
    Hintergrund
    Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases. Certain serine/threonine protein kinases, such as ASK-1 and RIP, are mediators of apoptosis. Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 for DAP kinase-related apoptosis-inducing protein kinases (1). DRAKs contain an N-terminal kinase domain and a C-terminal regulation domain. Overexpression of DRAK1 induces apoptosis. DRAKs have high sequence homology to DAP and ZIP kinases, and they represent a novel family of serine/threonine kinases, which mediates apoptosis through their catalytic activities. DRAK1 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues (1).Synonyms: DAP kinase-related apoptosis-inducing protein kinase 1, Serine/threonine-protein kinase 17A
    Gen-ID
    9263
    UniProt
    Q9UEE5
Sie sind hier:
Kundenservice